Leerink Partnrs Has Pessimistic View of Revvity Q4 Earnings

Revvity, Inc. (NYSE:RVTY) – Stock analysts at Leerink Partnrs dropped their Q4 2024 EPS estimates for shares of Revvity in a research note issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $1.37 for the quarter, down from their prior estimate of $1.38. The consensus estimate for Revvity’s current full-year earnings is $4.84 per share. Leerink Partnrs also issued estimates for Revvity’s FY2025 earnings at $5.08 EPS and FY2026 earnings at $5.72 EPS.

Several other equities analysts also recently weighed in on RVTY. Barclays decreased their price target on shares of Revvity from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a report on Friday, January 10th. TD Cowen lifted their price objective on Revvity from $141.00 to $144.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Raymond James dropped their target price on Revvity from $146.00 to $140.00 and set an “outperform” rating for the company in a report on Tuesday. Finally, Bank of America upgraded Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price target on the stock in a report on Friday, December 13th. Five research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Revvity has a consensus rating of “Moderate Buy” and a consensus target price of $132.00.

Revvity Trading Down 1.0 %

Shares of RVTY stock opened at $122.76 on Wednesday. Revvity has a fifty-two week low of $97.32 and a fifty-two week high of $129.50. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.97 and a current ratio of 3.56. The stock’s fifty day moving average is $114.96 and its two-hundred day moving average is $117.91. The firm has a market capitalization of $14.94 billion, a P/E ratio of 59.31, a PEG ratio of 3.50 and a beta of 1.03.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, November 4th. The company reported $1.28 EPS for the quarter, beating analysts’ consensus estimates of $1.13 by $0.15. The business had revenue of $684.10 million during the quarter, compared to analysts’ expectations of $679.66 million. Revvity had a return on equity of 7.42% and a net margin of 9.34%. The business’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 earnings per share.

Institutional Investors Weigh In On Revvity

Several institutional investors and hedge funds have recently modified their holdings of the company. EdgePoint Investment Group Inc. acquired a new stake in Revvity during the 2nd quarter worth approximately $209,221,000. Southpoint Capital Advisors LP acquired a new position in Revvity during the 3rd quarter worth approximately $25,550,000. Janus Henderson Group PLC increased its position in shares of Revvity by 1.7% in the 3rd quarter. Janus Henderson Group PLC now owns 6,335,302 shares of the company’s stock valued at $809,332,000 after purchasing an additional 108,401 shares during the last quarter. Holocene Advisors LP raised its holdings in shares of Revvity by 14.6% in the 3rd quarter. Holocene Advisors LP now owns 725,917 shares of the company’s stock valued at $92,736,000 after purchasing an additional 92,240 shares in the last quarter. Finally, Contravisory Investment Management Inc. lifted its position in shares of Revvity by 1,715.9% during the 4th quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company’s stock worth $7,722,000 after purchasing an additional 65,376 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Insider Buying and Selling at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the company’s stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares in the company, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.60% of the company’s stock.

Revvity announced that its board has authorized a share buyback plan on Monday, November 4th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 6.5% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its shares are undervalued.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.